Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 62170 record(s)

Req # A-2020-001817

All Briefing Notes, Issue sheets, Memorandums, Treasury Board Submissions, Standard Operating Processes, security assessment and incident templates, Internal Audits, PowerPoint presentations, and similar reports evaluating Health Canada’s readiness to handle cyber attacks and/or data breaches.Timeframe: January 1, 2018 to March 5, 2021.

Organization: Health Canada

115 page(s)
January 2024

Req # A-2021-000555

The document titled Expert Elicitation on the Behavioural impacts of Nicotine Standards which could explain how the five experts who were chosen and what process or data led to the experts decision that vaping was 20% as dangerous as smoking.

Organization: Health Canada

99 page(s)
January 2024

Req # A-2021-001762

All submissions received by the department further to its consultation on the subject of per- and polyfluoralkyl substances (PFAS) launched on April 24th, 2021.

Organization: Health Canada

135 page(s)
January 2024

Req # A-2021-001859

Any records on the human rights of intersex people, people with Differences in Sex Development (DSD), or people who underwent the surgeries. Any records on medical care to treat intersex people, DSD, or people who underwent the surgeries. Any records on the funding of medical care to treat intersex. people, DSD, or people who underwent the surgeries. Any records on the medical outcomes and prognosis of intersex people, DSD, or people who underwent the surgeries. Any records of consultations undertaken with intersex people, Intersex groups, people with DSD, or people who underwent the surgeries. Any records of the number of surgeries performed in Canada, individually and collectively. From 1993 to 2022-01-28.

Organization: Health Canada

77 page(s)
January 2024

Req # A-2021-001998

Documents regarding the approval process for Pfizer-BionTech BNT162b2 vaccine.

Organization: Health Canada

111 page(s)
January 2024

Req # A-2022-000412

For the period beginning January 1, 2021 to June 28, 2022, all records and documentation related to any complaints received and/or investigations conducted by Health Canada; and correspondence between Health Canada and Canadian Food Inspection Agency (CFIA) in respect of the compliance of BioSteel brand products with regulatory obligations, including those pertaining to product labelling, advertising and formulations.

Organization: Health Canada

62 page(s)
January 2024

Req # A-2022-000449

Correpondence relating to any abbreviated new drug submission filed since March 1, 2022 where the dosage form is a desmopressin orally disintegrating tablet (melt tablet). Exclude module 3 and 5.

Organization: Health Canada

1014 page(s)
January 2024

Req # A-2022-000909

The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431), which last received a Screening Acceptance Letter from Health Canada on March 7, 2022 for the sponsor’s Response to a Notice of Non-Compliance, dated August 23, 2021.

Organization: Health Canada

9 page(s)
January 2024

Req # A-2022-001171

All correspondence between Health Canada and British Colombia provincial organizations and/or officials on the matter of Delta-8-Tetrahydrocannabinol between June 1st 2022 and December 5, 2022.

Organization: Health Canada

171 page(s)
January 2024

Req # A-2022-001211

Number of memoranda of understanding on cooperation and information sharing with Indigenous communities signed in Quebec since the adoption of the Cannabis Act on October 17, 2018; document of the agreement with the Mohawk Council of Akwesasne; document of the agreement with the Mohawk Council of Kahnawà:ke; document of the agreement with Mohawk Council of Kanesatake. The number of inspections conducted by Health Canada in Indigenous communities in Quebec.

Organization: Health Canada

16 page(s)
January 2024
Date modified: